Contact: Emma Dickinson edickinson@bmj.com 44-207-383-6529 BMJ-British Medical Journal Joint BMJ/Channel 4 Dispatches investigation The BMJ and Channel 4 Dispatches investigated and found that evidence suggesting potential harm from the drugs in industry studies has not been published. Some independent studies… Read More ›
Glucagon-like peptide-1
Research suggests popular diabetes drugs can cause abnormal pancreatic growth in humans
Contact: Enrique Rivero erivero@mednet.ucla.edu 310-794-2273 University of California – Los Angeles Health Sciences Individuals who had taken a type of drug commonly used to treat Type 2 diabetes showed abnormalities in the pancreas, including cell proliferation, that may be associated… Read More ›
Johns Hopkins study: Risk of pancreatitis doubles for those taking new class of diabetes drugs
Contact: Stephanie Desmon sdesmon1@jhmi.edu 410-955-8665 Johns Hopkins Medicine People who take the newest class of diabetes drugs to control blood sugar are twice as likely as those on other forms of sugar-control medication to be hospitalized with pancreatitis, Johns Hopkins… Read More ›
Popular diabetes treatment could trigger pancreatitis, pancreatic cancer
2009 study posted for filing Contact: Enrique Rivero erivero@mednet.ucla.edu 310-794-2273 University of California – Los Angeles Drug’s adverse effects negated when combined with older diabetes drug A drug widely used to treat Type 2 diabetes may have unintended effects on… Read More ›
Engineering Evil 